---
schema_version: "secwatch.filing_event.v1"
accession: "0001099800-24-000054"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:02:44.303542+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Edwards Lifesciences principal accounting officer Sellers retires; Dahl named successor effective July 1

## Summary
- Robert W.A. Sellers, Senior VP and Principal Accounting Officer, retires effective July 1, 2024.
- Andrew M. Dahl, currently Senior VP and Corporate Controller, succeeds Sellers as Principal Accounting Officer.
- Dahl joined Edwards in February 2024; prior roles include VP at Medtronic and Manager at Deloitte.
- No material interest, arrangement, or family relationship exists between Dahl and Edwards officers or directors.

## SEC filing metadata
- accession: 0001099800-24-000054
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/0001099800-24-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/ew-20240614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001099800-24-000054
- JSON: https://secwatch.observer/filing/0001099800-24-000054.json
- Plain text: https://secwatch.observer/filing/0001099800-24-000054.txt

## Key facts
- Executive change
  Robert W.A. Sellers departed as Senior Vice President, Principal Accounting Officer at Edwards Lifesciences Corp.
  - Action: retire
  - Role: Senior Vice President, Principal Accounting Officer
  source text: Robert W.A. Sellers, Senior Vice President, Principal Accounting Officer of the Company, of his decision to retire, effective as of July 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/0001099800-24-000054-index.htm
- Executive change
  Andrew M. Dahl was appointed as Principal Accounting Officer at Edwards Lifesciences Corp.
  - Action: appointed
  - Role: Principal Accounting Officer
  source text: On the Retirement Date, Mr. Sellers will be succeeded by Andrew M. Dahl, currently Senior Vice President and Corporate Controller of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/0001099800-24-000054-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.